Discontinuation report PROVERA 2.5MG TABLETS
Report ID | 60112 |
Drug Identification Number | 00708917 |
Brand name | PROVERA 2.5MG TABLETS |
Common or Proper name | PROVERA |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | MEDROXYPROGESTERONE ACETATE |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1x500 |
ATC code | G03DA |
ATC description | PROGESTOGENS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-04-30 |
Actual discontinuation date | 2019-04-30 |
Remaining supply date | 2019-04-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Bottles of 1x100 available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2019-05-02 | French | Compare |
v10 | 2019-05-02 | English | Compare |
v9 | 2018-10-09 | French | Compare |
v8 | 2018-10-09 | English | Compare |
v7 | 2018-10-09 | French | Compare |
v6 | 2018-10-09 | English | Compare |
v5 | 2018-10-09 | English | Compare |
v4 | 2018-09-26 | French | Compare |
v3 | 2018-09-26 | English | Compare |
v2 | 2018-09-06 | French | Compare |
v1 | 2018-09-06 | English | Compare |
Showing 1 to 11 of 11